LONDON, April 21, 2015 /PRNewswire/ --
Whitehall-based consultancy celebrates Queen's Award for Enterprise, having achieved dazzling export-led growth in just 4 years.
PharmaGenesis London™ today celebrates its part in winning the Queen's Award for Enterprise, for Outstanding Achievement in International Trade, awarded to Oxford PharmaGenesis. As part of the world's first HealthScience Communications consultancy, PharmaGenesis London helps its clients bring new medicines to the world in areas of patient need. PharmaGenesis London™ has more than quadrupled its exports in just 3 years, from £280,000 in 2012 to £1.3 million in 2014. Approximately 90% of its income is earned abroad.
(Photo: http://photos.prnewswire.com/prnh/20150421/740336 )
Sustainable growth
PharmaGenesis London™ has grown steadily through repeat business and personal recommendation since Dr Catherine Hill opened the office in 2012. From premises overlooking Trafalgar Square, the company's 14 London-based employees now work with pharmaceutical clients around the world: 67% of its business is from mainland Europe and 22% from the USA. To support its global client base, PharmaGenesis London™ works closely with colleagues in Basel and Philadelphia, as well as in Oxford.
London pride
The success of PharmaGenesis London™ upholds the enduring power of the London name. Around the world, London has a reputation for high standards of science and medicine, and excellence in publishing. Dr Chris Winchester, Managing Director, comments, "London also means something more - energy and hard work, enabling us to get it right for the patients, clinicians and clients we work with every day."
Talent pool
PharmaGenesis London™ anticipates creating further highly skilled jobs. London offers an unrivalled pool of talented scientists and doctors with a flair for clear communication. It works hard to retain the talented people it recruits and develops, and clients value the continuity this approach provides. "Ours is a hugely satisfying company to work for, whose success is only made possible through the efforts of our high-performing teams," says Dr Richard White, Commercial Director.
Global growth
As Oxford PharmaGenesis continues to grow its business around the world, London will remain a key part of the company's success. Dr Chris Winchester, Managing Director, said, "As a proudly independent company owned by UK-based employee shareholders, we have the freedom to make the right decisions for our company, our clients and our employees. At Oxford PharmaGenesis, we are delighted to receive this prestigious award. We are looking forward to joining other award winners at Buckingham Palace later in the year."
Notes for Editors
About the Queen's Award
About PharmaGenesis London™
About Oxford PharmaGenesis
Further reading
The Queen's Award for Enterprise Magazine, 2015. Available from http://www.queensawardsmagazine.com/awardwinners/search, accessed 9 April 2015
Corfield R. The small, sane voices of big pharma. Oxford Times InBusiness Magazine, 15 May 2014, page 27 Available from http://www.oxfordtimes.co.uk/business/profiles/11210021.The_small__sane_voices_of_big_pharma/; accessed 9 April 2015.
Oxford PharmaGenesis website. http://www.pharmagenesis.com/ ; accessed 9 April 2015.
Contact
For further information, please contact:
Dr Catherine Hill
Communications Director, PharmaGenesis London™
catherine.hill@pharmagenesis.com
Office: +44-(0)20-3675-7062
Mobile: +44-(0)7824-902-922
Dr Chris Winchester
Managing Director, Oxford PharmaGenesis
chris.winchester@pharmagenesis.com
Office: +44-(0)1865-390144
Mobile: +44-(0)7803-196998
Share this article